Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricRMDResMedGEHCGE HealthCareDXCMDexcom
Snapshot
Price$224.92$66.08$89.89
Market cap$30.41B$29.82B$27.49B
Valuation
P/E21.5x16.1x37.6x
Forward P/E18.4x18.4x26.9x
Growth
Revenue growth10.3%6.0%16.1%
EPS growth16.5%-12.3%77.5%
Profitability
Net margin27.4%9.1%19.3%
ROE24.4%18.8%33.8%
Balance sheet & cash
Debt / equity0.11x0.97x0.47x
Free cash flow yield3.8%7.7%1.8%
Dividend yield1.2%0.2%—
Verdict
Investment ratingStrong· 75Neutral· 51Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearRMDtoday $225GEHCtoday $66DXCMtoday $90
2027$196.47 – $288.16+28% CAGR$50.55 – $74.14+12% CAGR$119.63 – $175.46+95% CAGR
2028$228.83 – $335.62+22% CAGR$51.56 – $75.62+7% CAGR$212.29 – $311.36+86% CAGR
2029$266.52 – $390.90+20% CAGR$52.59 – $77.14+5% CAGR$376.70 – $552.50+83% CAGR
2030$310.42 – $455.28+19% CAGR$53.65 – $78.68+4% CAGR$668.46 – $980.41+82% CAGR
2031$361.54 – $530.26+19% CAGR$54.72 – $80.25+4% CAGR$1,186.19 – $1,739.74+81% CAGR
5-yr CAGR10.0% – 18.7%-3.7% – 4.0%67.5% – 80.9%